Xiao Tong

Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens

Xiao Tong, Jeanon N. Smith, Natalya Bukreyeva et al. · Antiviral Research · 2017 · 81 citations

Molecular Virology, Emerging Infectious Diseases, Pathogenesis +9

Expression levels of hnRNP G and hTra2‐beta1 correlate with opposite outcomes in endometrial cancer biology

Yi Ouyang, Axel zur Hausen, Marzenna Orlowska‐Volk et al. · International Journal of Cancer · 2010 · 24 citations · Full text

Gynecology, Pathology, Hnrnp G +16

Physiologically based pharmacokinetic modelling to predict exposure differences in healthy volunteers and subjects with renal impairment: Ceftazidime case study

Li Zhou, Xiao Tong, Pradeep Sharma et al. · Basic & Clinical Pharmacology & Toxicology · 2019 · 22 citations · Full text

Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque–removing agent, in patients with Alzheimer’s disease

Kumar Kandadi Muralidharan, Xiao Tong, Kenneth G. Kowalski et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 22 citations · Full text

Quantitative Pharmacology, Pharmacotherapy, Population Pharmacokinetics +19

Population Pharmacokinetic Modeling With Enterohepatic Circulation for AZD3241 in Healthy Subjects and Patients With Multiple System Atrophy

Xiao Tong, Diansong Zhou, Alicia Savage et al. · The Journal of Clinical Pharmacology · 2018 · 14 citations

Translational Medicine, Pharmacokinetic Modeling, Healthy Subjects +15